221 related articles for article (PubMed ID: 15623556)
1. Normal gating of CFTR requires ATP binding to both nucleotide-binding domains and hydrolysis at the second nucleotide-binding domain.
Berger AL; Ikuma M; Welsh MJ
Proc Natl Acad Sci U S A; 2005 Jan; 102(2):455-60. PubMed ID: 15623556
[TBL] [Abstract][Full Text] [Related]
2. On the mechanism of MgATP-dependent gating of CFTR Cl- channels.
Vergani P; Nairn AC; Gadsby DC
J Gen Physiol; 2003 Jan; 121(1):17-36. PubMed ID: 12508051
[TBL] [Abstract][Full Text] [Related]
3. The two ATP binding sites of cystic fibrosis transmembrane conductance regulator (CFTR) play distinct roles in gating kinetics and energetics.
Zhou Z; Wang X; Liu HY; Zou X; Li M; Hwang TC
J Gen Physiol; 2006 Oct; 128(4):413-22. PubMed ID: 16966475
[TBL] [Abstract][Full Text] [Related]
4. The two nucleotide-binding domains of cystic fibrosis transmembrane conductance regulator (CFTR) have distinct functions in controlling channel activity.
Carson MR; Travis SM; Welsh MJ
J Biol Chem; 1995 Jan; 270(4):1711-7. PubMed ID: 7530246
[TBL] [Abstract][Full Text] [Related]
5. Prolonged nonhydrolytic interaction of nucleotide with CFTR's NH2-terminal nucleotide binding domain and its role in channel gating.
Basso C; Vergani P; Nairn AC; Gadsby DC
J Gen Physiol; 2003 Sep; 122(3):333-48. PubMed ID: 12939393
[TBL] [Abstract][Full Text] [Related]
6. Gating of cystic fibrosis transmembrane conductance regulator chloride channels by adenosine triphosphate hydrolysis. Quantitative analysis of a cyclic gating scheme.
Zeltwanger S; Wang F; Wang GT; Gillis KD; Hwang TC
J Gen Physiol; 1999 Apr; 113(4):541-54. PubMed ID: 10102935
[TBL] [Abstract][Full Text] [Related]
7. Differential interactions of nucleotides at the two nucleotide binding domains of the cystic fibrosis transmembrane conductance regulator.
Aleksandrov L; Mengos A; Chang X; Aleksandrov A; Riordan JR
J Biol Chem; 2001 Apr; 276(16):12918-23. PubMed ID: 11279083
[TBL] [Abstract][Full Text] [Related]
8. Mutation of Walker-A lysine 464 in cystic fibrosis transmembrane conductance regulator reveals functional interaction between its nucleotide-binding domains.
Powe AC; Al-Nakkash L; Li M; Hwang TC
J Physiol; 2002 Mar; 539(Pt 2):333-46. PubMed ID: 11882668
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase A regulates ATP hydrolysis and dimerization by a CFTR (cystic fibrosis transmembrane conductance regulator) domain.
Howell LD; Borchardt R; Kole J; Kaz AM; Randak C; Cohn JA
Biochem J; 2004 Feb; 378(Pt 1):151-9. PubMed ID: 14602047
[TBL] [Abstract][Full Text] [Related]
10. CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains.
Vergani P; Lockless SW; Nairn AC; Gadsby DC
Nature; 2005 Feb; 433(7028):876-80. PubMed ID: 15729345
[TBL] [Abstract][Full Text] [Related]
11. Thermodynamics of CFTR channel gating: a spreading conformational change initiates an irreversible gating cycle.
Csanády L; Nairn AC; Gadsby DC
J Gen Physiol; 2006 Nov; 128(5):523-33. PubMed ID: 17043148
[TBL] [Abstract][Full Text] [Related]
12. Stable ATP binding mediated by a partial NBD dimer of the CFTR chloride channel.
Tsai MF; Li M; Hwang TC
J Gen Physiol; 2010 May; 135(5):399-414. PubMed ID: 20421370
[TBL] [Abstract][Full Text] [Related]
13. Regulation of CFTR Cl- channel gating by ATP binding and hydrolysis.
Ikuma M; Welsh MJ
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8675-80. PubMed ID: 10880569
[TBL] [Abstract][Full Text] [Related]
14. Nucleotide-binding domains of cystic fibrosis transmembrane conductance regulator, an ABC transporter, catalyze adenylate kinase activity but not ATP hydrolysis.
Gross CH; Abdul-Manan N; Fulghum J; Lippke J; Liu X; Prabhakar P; Brennan D; Willis MS; Faerman C; Connelly P; Raybuck S; Moore J
J Biol Chem; 2006 Feb; 281(7):4058-68. PubMed ID: 16361259
[TBL] [Abstract][Full Text] [Related]
15. G551D and G1349D, two CF-associated mutations in the signature sequences of CFTR, exhibit distinct gating defects.
Bompadre SG; Sohma Y; Li M; Hwang TC
J Gen Physiol; 2007 Apr; 129(4):285-98. PubMed ID: 17353351
[TBL] [Abstract][Full Text] [Related]
16. Cystic fibrosis transmembrane conductance regulator: a chloride channel gated by ATP binding and hydrolysis.
Bompadre SG; Hwang TC
Sheng Li Xue Bao; 2007 Aug; 59(4):431-42. PubMed ID: 17700963
[TBL] [Abstract][Full Text] [Related]
17. The Walker B motif of the second nucleotide-binding domain (NBD2) of CFTR plays a key role in ATPase activity by the NBD1-NBD2 heterodimer.
Stratford FL; Ramjeesingh M; Cheung JC; Huan LJ; Bear CE
Biochem J; 2007 Jan; 401(2):581-6. PubMed ID: 16989640
[TBL] [Abstract][Full Text] [Related]
18. Cysteine accessibility probes timing and extent of NBD separation along the dimer interface in gating CFTR channels.
Chaves LA; Gadsby DC
J Gen Physiol; 2015 Apr; 145(4):261-83. PubMed ID: 25825169
[TBL] [Abstract][Full Text] [Related]
19. Control of the CFTR channel's gates.
Vergani P; Basso C; Mense M; Nairn AC; Gadsby DC
Biochem Soc Trans; 2005 Nov; 33(Pt 5):1003-7. PubMed ID: 16246032
[TBL] [Abstract][Full Text] [Related]
20. Covalent modification of the nucleotide binding domains of cystic fibrosis transmembrane conductance regulator.
Cotten JF; Welsh MJ
J Biol Chem; 1998 Nov; 273(48):31873-9. PubMed ID: 9822656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]